Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoe S Kopp

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Nature Reviews. Urology|July 6, 2011
The placebo effect in overactive bladder syndromeAltaf Mangera, Christopher R Chapple, Zoe S Kopp, et al.
Urology|November 8, 2011
Racial differences in the prevalence of overactive bladder in the United States from the epidemiology of LUTS (EpiLUTS) studyKarin S Coyne, Mary Kay Margolis, Zoe S Kopp, et al.
BJU International|January 15, 2011
Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstructionDebra E Irwin, Zoe S Kopp, Barnabie Agatep, et al.
International Urogynecology Journal|July 9, 2011
The psychometric validation of a 1-week recall period for the OAB-qKarin S Coyne, Heather Gelhorn, Christine Thompson, et al.
BJU International|December 2, 2011
Sustained improvement in patient-reported outcomes during long-term fesoterodine treatment for overactive bladder symptoms: pooled analysis of two open-label extension studiesCon J Kelleher, Roger R Dmochowski, Sandra Berriman, et al.
The Journal of Urology|July 4, 2006
Determining the importance of change in the overactive bladder questionnaireKarin S Coyne, Louis S Matza, Christine L Thompson, et al.
Urology|July 4, 2012
Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTSIan Milsom, Steven A Kaplan, Karin S Coyne, et al.
Urology|January 25, 2011
National community prevalence of overactive bladder in the United States stratified by sex and ageKarin S Coyne, Chris C Sexton, Vasudha Vats, et al.
Neurourology and Urodynamics|June 8, 2012
LUTS patient reported outcomes tool: linguistic validation in 10 European languagesBarbara A Brandt, Çolpan Angün, Karin S Coyne, et al.
The Journal of Sexual Medicine|April 16, 2011
The impact of OAB on sexual health in men and women: results from EpiLUTSKarin S Coyne, Chris C Sexton, Christine Thompson, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Nature Reviews. Urology|July 6, 2011
The placebo effect in overactive bladder syndromeAltaf Mangera, Christopher R Chapple, Zoe S Kopp, et al.
Urology|November 8, 2011
Racial differences in the prevalence of overactive bladder in the United States from the epidemiology of LUTS (EpiLUTS) studyKarin S Coyne, Mary Kay Margolis, Zoe S Kopp, et al.
BJU International|January 15, 2011
Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstructionDebra E Irwin, Zoe S Kopp, Barnabie Agatep, et al.
International Urogynecology Journal|July 9, 2011
The psychometric validation of a 1-week recall period for the OAB-qKarin S Coyne, Heather Gelhorn, Christine Thompson, et al.
BJU International|December 2, 2011
Sustained improvement in patient-reported outcomes during long-term fesoterodine treatment for overactive bladder symptoms: pooled analysis of two open-label extension studiesCon J Kelleher, Roger R Dmochowski, Sandra Berriman, et al.
The Journal of Urology|July 4, 2006
Determining the importance of change in the overactive bladder questionnaireKarin S Coyne, Louis S Matza, Christine L Thompson, et al.
Urology|July 4, 2012
Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTSIan Milsom, Steven A Kaplan, Karin S Coyne, et al.
Urology|January 25, 2011
National community prevalence of overactive bladder in the United States stratified by sex and ageKarin S Coyne, Chris C Sexton, Vasudha Vats, et al.
Neurourology and Urodynamics|June 8, 2012
LUTS patient reported outcomes tool: linguistic validation in 10 European languagesBarbara A Brandt, Çolpan Angün, Karin S Coyne, et al.
The Journal of Sexual Medicine|April 16, 2011
The impact of OAB on sexual health in men and women: results from EpiLUTSKarin S Coyne, Chris C Sexton, Christine Thompson, et al.
Pageof 3